Key Factors Abstract
- Asia’s GLP‑1 uptake has lagged the West however is primed for speedy acceleration as weight problems charges rise and authorities urgency grows
- China and India are driving demand shifts as diets westernise and metabolic illness climbs
- Value boundaries are falling: native corporations in China and India are creating cheaper semaglutide generics, forcing worth cuts
- Mintel forecasts “explosive development”, with China probably turning into the world’s No1 GLP‑1 market by 2030
- Security fears persist in China (uncomfortable side effects, “rebound”, “semaglutide face”) and in India (strict guidelines on drug promotion)
GLP-1 agonist medicine have revolutionised weight reduction in the US and elements of Europe, offering – generally – a extremely efficient strategy to handle the ballooning subject of weight problems in these markets.
In Asia, the urge for food for GLP-1 agonists for weight administration has been much less voracious. Value and accessibility have been cited because the essential boundaries to their use, though there have been different points moderating their uptake.
“In lots of APAC markets the place healthcare spending is essentially out of pocket, adoption tends to be slower,” explains FMCG guide Veena Giridhar-Gopal, including that the ‘demand profile’ has historically differed from that of western markets.
“Throughout a lot of the area, GLP-1 therapies usually tend to be pushed by diabetes and metabolic illness administration than for weight reduction.”
Additionally learn → GLP-1 meals in Asia: State of the market and key challenges
That ‘demand profile’ has already began to shift. Weight problems charges in most areas are on the rise – notably in China and India, the place many are edging away from conventional Asian diets to extra calorific western-style meals. In consequence, governments are in search of swift options to handle their nations’ rising waistlines.
May GLP-1 agonists be the reply they’re searching for?
‘Sure’, says Jonny Forsyth, principal strategist at Mintel Meals & Drink, who thinks we’re set to see ‘explosive development’ of GLP-1s in Asia this coming 12 months.
“Our information reveals that there’s robust curiosity in GLP-1s for weight reduction in Asia,” he says.
“For instance, 68% of Indian adults want to know the way drugs that cut back urge for food might help with their very own weight administration, second solely to Nigeria among the many 36 totally different international locations we polled.”
China is arguably most determined for a fast resolution to sort out quickly rising charges of weight problems. A latest survey in medical journal The Lancet suggests about half of adults and 20% of youngsters are overweight.
Then there may be the truth that Indian and Chinese language corporations are in late-stage trials with cheaper generics because the patent for semaglutide expires in Asia, provides Forsyth.
“This has already compelled Novo Nordisk to dramatically cut back costs of Ozempic, and if generics value as little as US$100 monthly or much less, as mooted, that may make them accessible to a a lot wider user-base.”
If these value and accessibility boundaries had been to carry, there are robust indications that GLP-1 utilization couldn’t solely enhance in Asia, however in some markets, overtake that within the west, says Mintel.
“In accordance with our mannequin, China has the potential to be the primary GLP-1 utilization market on the planet by 2030,” confirms Forsyth.
Nevertheless, there are some hurdles GLP-1 producers might want to leap earlier than this occurs in Asia’s second most populated nation.
The uncomfortable side effects – some probably deadly – reported by the Medicines and Healthcare Merchandise Regulatory Company (MHRA) and information experiences throughout the west, highlighting how sufferers regain weight when they’re now not taking GLP-1s, might imply many Chinese language sufferers will likely be anxious about taking these medicine.
“Chinese language shoppers prioritise security after they select weight reduction merchandise, that means the potential uncomfortable side effects of taking GLP-1 medicine, similar to nausea, rebound impact and ‘semaglutide face’ might forestall folks from taking this medication for weight reduction functions,” says Forsyth.
In India, the federal government has additionally cautioned pharmaceutical corporations in opposition to selling prescription weight reduction medicine, like GLP-1s, straight or not directly to the general public for worry sufferers will request them with out correct medical analysis.
The assertion from India’s Central Medication Customary Management Organisation (CDSCO) additionally mentioned any marketing campaign that promoted unrealistic expectations about weight reduction would contravene Medication Guidelines 1945.
Nutrient-rich meals
These considerations are all legitimate, however cases of the ‘rebound impact’ highlighted within the western press have been because of sufferers returning to their former consuming habits after they cease taking the drug.
GLP-1 agonist receptors work by mimicking a hormone made by the small gut which regulates blood sugar ranges, slows digestion and will increase satiety after consuming. Briefly, they curb the customers’ appetites in order that they eat much less.
Avoiding the rebound, subsequently, lies within the GLP-1 affected person’s capacity to embrace more healthy consuming whereas on the medicine after which sustaining these new habits after they end taking them, explains UK dietician and nutritionist, Dr Sarah Schenker.
So what precisely does ‘more healthy consuming’ imply in context of GLP-1 use and the way can or not it’s adopted throughout and after taking it to keep away from weight returning?
Schenker advocates ‘squeezing nutrient-rich components into smaller meals’, as an example, including fruit, nuts and seeds to salads, or to a protein like egg, fish or lean meats, whereas eschewing nutrient poor refined carbohydrates similar to bread and white rice.
“It’s not all about energy, it’s about getting vitamins from meals,” she explains, “so you must assume extra fastidiously about getting these vitamins from a smaller consumption.”
Schenker says usually excessive calorie carbohydrates – like rice and bread – function a automobile to help consumption of different meals, making them a no-go for these on a weight-loss journey. As an alternative, she suggests GLP-1 customers swap these for much less calorific choices, similar to different greens as an alternative of rice, or noodles; or a lettuce leaf as an alternative of bread.
Incorporating protein into each meal can be advisable – each throughout and post-GLP-1 – to take care of muscle mass, one thing Schenker says Asian shoppers sometimes do – consciously or not – already. This units them off on the correct foot for dietary behavior adjustments.
As GLP-1 adoption grows, demand for calorie-dense snacks, quick meals, and ultra-processed meals is anticipated to say no
Jonny Forsyth, Mintel Meals & Drink
“One of many actual positives about typical Asian diets that may work in favour of GLP-1 is that protein distribution all through the day is healthier,” she continues, stating that conventional Asian breakfasts usually include protein-rich beans and legumes, versus refined carbohydrate-heavy typical western breakfasts of cereals and toast.
These ideas present a stronger basis for improved diets and counsel that Asia might expertise sustained success if adopting GLP-1 agonist receptors for weight reduction. This, teamed with Asia’s ‘openness to new applied sciences and a want for an answer for weight administration that really works’, add credence to the argument that GLP-1s will likely be well-received throughout this market, says Forsyth.
Amy Stobie, a advertising and communications professional whose expertise spans FMCG, healthcare, prescribed drugs, and nutritional vitamins, minerals and dietary supplements (VMS), says China’s Wholesome China Initiative, launched in 2019 makes it well-prepared to help residents who’re prescribed GLP-1s for weight reduction.
“China’s well being messaging has lengthy framed weight problems as a persistent illness, which has educated the inhabitants on the necessity to take a sustained strategy to weight administration,” she says.
In China, she notes, the healthcare system ‘focuses on life-style and behavioural adjustments’ which embody the supply of diet plans, counselling and train programmes from devoted weight administration centres.
As dietician Schenker factors out, GLP-1 sufferers who handle to maintain the load off when end taking the medicine have achieved so as a result of they’ve modified consuming habits and mindset for good. In China, GLP-1 agonists might subsequently function the catalyst for weight reduction earlier than these essential life-style adjustments kick in.
China’s bundle of healthcare help is spectacular, however let’s not overlook that the explanation it exists within the first place is to sort out excessive weight problems charges.
How can FMCG help GLP-1 customers?
And one of many causes for rising weight problems is dangerous weight loss plan with the rising consumption of high-calorie quick meals and snacks contributing. If GLP-1 is to work successfully, meals manufacturers with an present presence in Asia might want to cease peddling excessive calorie snacks and step up as GLP-1 companions.
So how can FMCG manufacturers help – and profit from – wider GLP-1 take up?
Giridhar-Gohal, who has spent the final 25 years working in FMCG and retail with international companies similar to Diageo and PepsiCo, says there are alternatives for corporations that may develop merchandise that ship excessive dietary worth in smaller codecs, similar to ‘protein-forward snacks, fibre-rich meals that help satiety, portion-controlled merchandise, and nutrient-dense mini-meals or practical drinks’.
“In Asian markets the place meals is deeply social and cultural, positioning round nourishment and high quality is more likely to resonate extra strongly than conventional ‘weight loss plan’ framing,” she provides.
Forsyth says GLP-1 customers will likely be actively in search of meals that ship extra diet in smaller parts, notably high-protein, high-fibre snacks which might be wealthy in nutritional vitamins in minerals.
Additionally learn → GLP-1 drinks are taking off all over the world
He factors in the direction of manufacturers like Nestlé which launched GLP-1 companion model Important Pursuit – a variety of portion-controlled high-protein, excessive fibre and nutrient dense prepared meals – within the US on the finish of 2024 and Danone with its GLP-1 pleasant yoghurt Oikos Fusion.
There’s some proof that manufacturers are already on this area in Asia. Healthcare firm Abbott launched vanilla diet shake Protality – a product which particularly targets GLP-1 drug customers to deal with nutrient deficiencies and muscle mass loss – in Korea.
And final month, Nestlé introduced it was launching a brand new ‘science-backed dietary drinks’ vary – Nestlé Important – in Latin America with plans to launch it in Europe and Asia later this 12 months.
There are additionally a rising variety of practical meals hitting the market, providing dietary options that GLP-1 customers search. Innova Market Insights experiences a 32% rise year-on-year within the variety of merchandise carrying a excessive protein declare.
Stobie recommends manufacturers, notably within the VMS area, additionally examine the merchandise GLP-1 customers might want to help their well being to get forward with NPD.
“For instance, Ozempic slows digestion and reduces urge for food,” she explains. “In consequence, many individuals develop into poor in vitamin D, B12, iron and zinc. Pores and skin can develop into saggy, which collagen dietary supplements might help.”
There’s additionally an opportunity for nutrition-led manufacturers with a presence in China to combine with the nation’s wrap-around weight reduction companies, she says.
“There are robust alternatives for FMCG manufacturers that may work in synergy with this technique. Manufacturers that seem in a well being setting develop credibility with sufferers, as a result of the merchandise are psychologically acquired to have the identical high quality and authority they obtain from care suppliers.”
She advises a ‘cautious and deliberate’ integration that may align manufacturers with sufferers at each step – from preliminary visits to weight reduction centres, proper by means of to follow-up appointments submit GLP-use. Tie-ups with non-food manufacturers – in sportswear for instance – might be the subsequent step.
“Shoppers utilizing GLP-1 will wish to see how a product suits into their lives and perceive the way it can help them.”
Returning to Giridhar-Gopal’s earlier level about nourishment and high quality, Forsyth thinks meals or meals with components that deliver extra satiety, like konjak, and that entice shoppers with ‘pure GLP-1’ as their promoting level, will develop into extra fashionable.
Schenker agrees, suggesting that protein taken in a extra pure meals type – in yoghurt, fish or egg for instance – moderately than in processed powders or bars, could have larger attraction amongst these on GLP-1.
Concluding, Forsyth predicts a see-saw have an effect on with rising GLP-1 agonist receptor use prompting a reorientation of class gross sales as producers realise that buyers are altering what they put of their procuring baskets.
“As GLP-1 adoption grows, demand for calorie-dense snacks, quick meals, and ultra-processed meals is anticipated to say no, whereas more healthy choices, particularly fruits, greens, and protein-rich meals, will see development,” he says.
